Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

BusinesswireDec 16 21:29 ET

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

PR NewswireNov 12 16:58 ET

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 8 07:35 ET · Ratings

Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 7 08:31 ET · Ratings

Vanda Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 7 07:13 ET · Announcements

Express News | Vanda Pharmaceuticals Inc : Jefferies Cuts Target Price to $5.5 From $6

ReutersNov 7 05:51 ET